We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Actavis Acquires U.S.-based Abrika Pharmaceuticals
Actavis announced an agreement to acquire all controlling shares of Abrika Pharmaceuticals, a specialty generic drugmaker focused on developing controlled-release pharmaceuticals.